Healthcare Services

Cloud-Based Rare Disease Family Registry Market Outlook 2026–2030 Exploring New Business Opportunities

March 31, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Cloud-Based Rare Disease Family Registry Market Expected To Change Between 2026 And 2030?

The cloud-based rare disease family registry market has demonstrated significant expansion in recent years. It is anticipated to increase from $1.4 billion in 2025 to $1.65 billion in 2026, driven by a compound annual growth rate (CAGR) of 17.7%. The historical growth of this market can be ascribed to several factors, including the proliferation of rare disease research initiatives, heightened patient advocacy involvement, the enlargement of clinical trial networks, the increasing adoption of electronic data capture tools, and the necessity for centralized patient data systems.

The cloud-based rare disease family registry market is poised for significant expansion in the upcoming years. This sector is forecast to swell to $3.15 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.5%. This anticipated growth is driven by factors such as heightened investments in orphan drug development, a burgeoning demand for real-world evidence generation, the widening scope of precision medicine research, the increasing application of AI-driven data analytics, and a greater focus on patient-centric research models. Over the forecast period, prominent trends are expected to include the broader uptake of cloud-based patient registries, an increased reliance on digital platforms for rare disease research, deeper integration of genomic and clinical data, the expansion of global clinical trial recruitment tools, and a reinforced emphasis on secure data sharing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28178&type=smp

Which Major Factors Are Driving The Expansion Of The Cloud-Based Rare Disease Family Registry Market?

The growing emphasis on precision medicine is anticipated to propel the expansion of the cloud-based rare disease family registry market moving forward. Precision medicine is a medical strategy that customizes treatment and prevention plans to an individual’s genetic, environmental, and lifestyle factors. The adoption of precision medicine is increasing due to advancements in genomic sequencing, which enable doctors to understand patients’ genetic makeup more accurately. Cloud-based rare disease family registries facilitate precision medicine by collecting and centralizing comprehensive patient data, including genetic, clinical, and treatment information. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the Food and Drug Administration (FDA), a US-based federal agency, approved 16 new personalized therapies for patients with rare diseases. This marked a notable rise from the six approvals in 2022; of these newly authorized treatments, seven target cancer, while three focus on other diseases and conditions. Therefore, the increasing focus on precision medicine is driving the growth of the cloud-based rare disease family registry market.

How Is The Cloud-Based Rare Disease Family Registry Market Structured Across Different Segments?

The cloud-based rare disease family registry market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Public Cloud, Private Cloud, Hybrid Cloud

3) By Application: Patient Data Management, Research, Clinical Trials, Genetic Data Collection, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Patient Advocacy Groups, Other End-Users

Subsegments:

1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System

2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades

What Trends Are Advancing Progress In The Cloud-Based Rare Disease Family Registry Market?

Major companies in the cloud-based rare disease family registry market are advancing technological innovations, such as bilingual federated registries. These innovations provide patients, families, and researchers with secure, multi-location data platforms that enhance participation and support real-time data collection and analysis. A bilingual federated registry is a cloud-based system that allows data to remain at local sites while supporting multiple languages and complying with regional consent and privacy regulations. For instance, in June 2025, the National Organization for Rare Disorders (NORD), a U.S.-based nonprofit, planned the launch of two Canadian patient registries for PKU and MPS. Developed in collaboration with Canadian patient advocacy groups, researchers, and clinicians, these registries are the first in the IAMRARE Program to be hosted outside the U.S. They are designed to comply with provincial consent requirements, enable cooperative real-time data collection and analysis, and support efforts to accelerate research, improve understanding of rare metabolic disorders, and facilitate identification of participants for clinical trials.

Which Major Players Dominate The Cloud-Based Rare Disease Family Registry Market?

Major companies operating in the cloud-based rare disease family registry market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., ICON plc, Syneos Health Inc., Parexel International Corp., Medidata Solutions Inc., FIGMD Inc., OM1 Inc., Mission Health Labs Inc., TREAT-NMD Global Registries Platform, Seqster PDM Inc., ArborMetrix Inc., OpenClinica LLC, Pulse Infoframe Inc., Oracle Healthcare Pvt. Ltd., QuesGen Systems Inc., FTD Disorders Registry, Castor LLC, Data Registry Services LLC, Fibrolamellar Registry, Rare Central

Read the full cloud-based rare disease family registry market report here:

https://www.thebusinessresearchcompany.com/report/cloud-based-rare-disease-family-registry-global-market-report

Which Region Currently Holds The Largest Share Of The Cloud-Based Rare Disease Family Registry Market?

North America was the largest region in the cloud-based rare disease family registry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud-based rare disease family registry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cloud-Based Rare Disease Family Registry Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28178&type=smp

Browse Through More Reports Similar to the Global Cloud-Based Rare Disease Family Registry Market 2026, By The Business Research Company

Cloud Based Data Management Services Global Market Report

https://www.thebusinessresearchcompany.com/report/cloud-based-data-management-services-global-market-report

Healthcare Cloud Infrastructure Global Market Report

https://www.thebusinessresearchcompany.com/report/healthcare-cloud-infrastructure-global-market-report

Facility Management Services Global Market Report

https://www.thebusinessresearchcompany.com/report/facility-management-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795